AMETHOPTERIN IN THE TREATMENT OF TROPHOBLASTIC TUMORS
Constantino P. Manahan, Isidro Benitez, Felipe Estrella
Abstract
Constantino P. Manahan, Isidro Benitez, Felipe Estrella
Abstract
Abstract 1. 1. Three patients with histologically confirmed chorioadenoma destruens with extension and a patient with probable chorioadenoma were treated with amethopterin and all may be considered cured. 2. 2. Twelve patients with histologically proved choriocarcinoma with metastases were treated with amethopterin. Five after 3 years are clinically normal. These represent a 41 per cent 3 year salvage. Four patients with choriocarcinoma with metastases, after repeated courses of amethopterin treatment, have shown considerable improvement but still show residual lesions during a follow-up of 1 to 2 years. Three patients died from drug toxicity during the course of this 3 year study.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract 1. 1. Three patients with histologically confirmed chorioadenoma destruens with extension and a patient with probable chorioadenoma were treated with amethopterin and all may be considered cured. 2. 2. Twelve patients with histologically proved choriocarcinoma with metastases were treated with amethopterin. Five after 3 years are clinically normal. These represent a 41 per cent 3 year salvage. Four patients with choriocarcinoma with metastases, after repeated courses of amethopterin treatment, have shown considerable improvement but still show residual lesions during a follow-up of 1 to 2 years. Three patients died from drug toxicity during the course of this 3 year study.
Key concepts: Amethopterin, Medicine, Choriocarcinoma, Methotrexate, Surgery, Internal medicine